ARVO 2023: Early detection of diabetic retinopathy in underserved communities

Article

Dr Edmund Arthur shares his research on the early detection of diabetic retinopathy in underserved communities at this year's ARVO meeting.

Dr Edmund Arthur shares his research on the early detection of diabetic retinopathy in underserved communities at this year's ARVO meeting.

Video transcript

Editor’s note: Transcript lightly edited for clarity.

Edmund Arthur, OD, PhD, FAAO:

I'm Edmund Arthur. I'm an assistant professor of the University of Alabama at Birmingham School of Optometry. I'm this year's Genentech Career Development Award recipient for Underrepresented Emerging Vision Scientists. My research is on the early detection of diabetic retinopathy in underserved communities.

Diabetic retinopathy is the most common cause of vision loss in working-age adults in most developed countries, including the United States. Early detection of this condition will lead to early refer out to a primary care physician for control of systemic glucose or systemic A1C. But the pathological changes that occur in diabetic patients precedes clinical retinopathy. In other words, the changes are occurring in diabetic patients, you know, okay, long before they are clinically detected. So if we can detect these early changes with advanced retinal imaging, then we can refer to a primary care physician and then start early management of their systemic A1C and yet systemic glucose.

So the focus of my research that is sponsored generously by Genentech is to use advanced retinal imaging called optical coherence tomography angiography to develop a novel retinal vascular biomarker for early detection of diabetic retinopathy and diabetic macular edema, so that we can refer to the primary care physician early enough, and then we can manage this condition early enough. Thank you.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Related Content
© 2025 MJH Life Sciences

All rights reserved.